-
Je něco špatně v tomto záznamu ?
The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula
Vojtech Melenovsky, Petra Skaroupkova, Jan Benes, VeraTorresova, Libor Kopkan, Ludek Cervenka
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10497
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2010
ProQuest Central
od 1994-05-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2005-01-01
Health & Medicine (ProQuest)
od 1994-05-01 do Před 1 rokem
ROAD: Directory of Open Access Scholarly Resources
od 1996
PubMed
22116309
DOI
10.1159/000331562
Knihovny.cz E-zdroje
- MeSH
- aorta abdominalis abnormality MeSH
- arteriovenózní píštěl komplikace mortalita patofyziologie MeSH
- kardiomegalie etiologie mortalita patofyziologie MeSH
- krysa rodu rattus MeSH
- míra přežití trendy MeSH
- potkani Wistar MeSH
- srdeční selhání etiologie mortalita patofyziologie MeSH
- vena cava inferior abnormality MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: There are only few studies documenting the long-term outcome of aorto-caval fistula (ACF) in rats, a model of volume overload heart failure (HF). The aim of the present study was to describe HF-related morbidity and mortality, and to examine the relation between cardiac hypertrophy and survival. METHODS: Adult male Wistar rats underwent needle ACF or sham operation and 71 animals surviving the acute procedure with patent ACF were followed for 52 weeks. RESULTS: By the end of the study, 72% of the ACF animals deceased and 82% developed HF signs. Of the HF rats, 65% died (median: 3 weeks after HF onset). Before death, body weight increased by 9% followed by a final drop. 28% ACF rats died suddenly, without preceding HF. Sudden death occurred earlier and in the rats with a trend to larger hearts (p = 0.07). In the whole ACF cohort, heart weight (heart weight/body weight ratio) was inversely associated with the length of survival (r = -0.51, p < 0.001). CONCLUSION: The median survival of ACF Wistar rats is 43 weeks, longer than reported in other rat strains. Increased heart weight is associated with higher mortality and a significant number of animals die suddenly.
Center for Cardiovascular Research Institute for Clinical and Experimental Medicine IKEM Prague
Department of Cardiology Institute for Clinical and Experimental Medicine IKEM Prague Czech Republic
Department of Physiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012766
- 003
- CZ-PrNML
- 005
- 20180308091623.0
- 007
- ta
- 008
- 130404s2012 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000331562 $2 doi
- 035 __
- $a (PubMed)22116309
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Melenovský, Vojtěch $7 xx0160847 $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic
- 245 14
- $a The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula / $c Vojtech Melenovsky, Petra Skaroupkova, Jan Benes, VeraTorresova, Libor Kopkan, Ludek Cervenka
- 520 9_
- $a BACKGROUND: There are only few studies documenting the long-term outcome of aorto-caval fistula (ACF) in rats, a model of volume overload heart failure (HF). The aim of the present study was to describe HF-related morbidity and mortality, and to examine the relation between cardiac hypertrophy and survival. METHODS: Adult male Wistar rats underwent needle ACF or sham operation and 71 animals surviving the acute procedure with patent ACF were followed for 52 weeks. RESULTS: By the end of the study, 72% of the ACF animals deceased and 82% developed HF signs. Of the HF rats, 65% died (median: 3 weeks after HF onset). Before death, body weight increased by 9% followed by a final drop. 28% ACF rats died suddenly, without preceding HF. Sudden death occurred earlier and in the rats with a trend to larger hearts (p = 0.07). In the whole ACF cohort, heart weight (heart weight/body weight ratio) was inversely associated with the length of survival (r = -0.51, p < 0.001). CONCLUSION: The median survival of ACF Wistar rats is 43 weeks, longer than reported in other rat strains. Increased heart weight is associated with higher mortality and a significant number of animals die suddenly.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aorta abdominalis $x abnormality $7 D001012
- 650 _2
- $a arteriovenózní píštěl $x komplikace $x mortalita $x patofyziologie $7 D001164
- 650 _2
- $a kardiomegalie $x etiologie $x mortalita $x patofyziologie $7 D006332
- 650 _2
- $a srdeční selhání $x etiologie $x mortalita $x patofyziologie $7 D006333
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a míra přežití $x trendy $7 D015996
- 650 _2
- $a vena cava inferior $x abnormality $7 D014682
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Škaroupková, Petra $7 xx0117683 $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Beneš, Jan, $d 1983- $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic $7 xx0221722
- 700 1_
- $a Torresová, Věra $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Kopkan, Libor $u Center for Cardiovascular Research, Institute for Clinical and Experimental Medicine – IKEM, Prague
- 700 1_
- $a Červenka, Luděk $u Department of Physiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 35, č. 3 (2012), s. 167-173
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22116309 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20180308091625 $b ABA008
- 999 __
- $a ok $b bmc $g 975964 $s 811047
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 35 $c 3 $d 167-173 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- GRA __
- $a NS10497 $p MZ0
- LZP __
- $a Pubmed-20130404